Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 176

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 176
---
.
Holder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, is attributable to the Non-U.S. Holder’s permanent establishment in the United
States). Because it may not be certain at the time of the Merger whether dividend treatment applies, and because such application depends on a Non-U.S. Holder’s particular circumstances, withholding
agents may not be able to determine whether (or to what extent) a Non-U.S. Holder is treated as receiving a dividend for U.S. federal income tax purposes. Therefore, withholding agents may withhold tax at a
rate of 30% (or such lower rate as may be provided by an applicable income tax treaty) on the gross amount of any cash Merger Consideration payable to a Non-U.S. Holder.

Information reporting and backup withholding tax

The receipt of the Merger Consideration in exchange for Enfusion Common Stock pursuant to the Merger may be subject, under certain
circumstances, to information reporting and backup withholding at a rate of 24%. To avoid backup withholding, a U.S. Holder should timely complete and return an IRS Form W-9, certifying that such U.S. Holder
is a “United States person” (within the meaning of the Code), that the taxpayer identification number provided is correct and that such U.S. Holder is not subject to backup withholding. Certain types of U.S. Holders (including, with
respect to certain types of payments, corporations) generally are not subject to backup withholding.

A
Non-U.S. Holder may be subject to information reporting and backup withholding at a rate of 24% unless the Non-U.S. Holder establishes an exemption, for example, by
completing an applicable IRS Form W-8 in accordance with the instructions to the appropriate form.

Any amount withheld under the backup withholding rules will be allowed as a refund or credit against the United States federal income tax
liability of a Enfusion Stockholder, provided the stockholder timely files the appropriate claim for a refund with the IRS and timely furnishes any required information to the IRS. The IRS may impose a penalty upon an Enfusion Stockholder
that fails to provide the correct taxpayer identification number.

The foregoing summary of United States federal income tax consequences is for general informational purposes only and does not constitute tax advice. All holders are urged to consult their own tax advisors with respect to the application of United States federal income tax laws to their particular situations as well as any tax consequences arising under